SOX9 is a dose-dependent metastatic fate determinant in melanoma

BACKGROUND: In this research, we aimed to resolve contradictory results whether SOX9 plays a positive or negative role in melanoma progression and determine whether SOX9 and its closely related member SOX10 share the same or distinct targets in mediating their functions in melanoma. METHODS: Immunof...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Yang, Xintao, Liang, Rui, Liu, Chunxi, Liu, Jessica Aijia, Cheung, May Pui Lai, Liu, Xuelai, Man, On Ying, Guan, Xin-Yuan, Lung, Hong Lok, Cheung, Martin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330758/
https://ncbi.nlm.nih.gov/pubmed/30642390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0998-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars